Randomized controlled clinical trial 52 overweight/obese women with T2DM Patients received either 10 g/d of oligofructose-enriched inulin or maltodextrin (control) for 8 weeks oligofructose-enriched-Inulin: ↓ CRP, TNF-α and LPS Dehghan et al. (2014b)